Literature DB >> 25858034

Regioselective sulfamoylation at low temperature enables concise syntheses of putative small molecule inhibitors of sulfatases.

Duncan C Miller1, Benoit Carbain, Gary S Beale, Sari F Alhasan, Helen L Reeves, Ulrich Baisch, David R Newell, Bernard T Golding, Roger J Griffin.   

Abstract

Regioselective sulfamoylation of primary hydroxyl groups enabled a 5-step synthesis (overall yield 17%) of the first reported small molecule inhibitor of sulfatase-1 and 2, ((2S,3R,4R,5S,6R)-4,5-dihydroxy-2-methoxy-6-((sulfamoyloxy)methyl)tetrahydro-2H-pyran-3-yl)sulfamic acid, which obviated the use of hydroxyl protecting groups and is a marked improvement on the reported 9-step synthesis (overall yield 9%) employing hazardous trifluoromethylsulfonyl azide. The sulfamoylation methodology was used to prepare a range of derivatives of 1, and inhibition data was generated for Sulf-2, ARSA and ARSB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25858034     DOI: 10.1039/c5ob00211g

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Stereospecific synthesis of methyl 2-amino-2-deoxy-(6S)-deuterio-α,β-d-glucopyranoside and methyl 2,6-diamino-2,6-dideoxy-(6R)-deuterio-α,β-d-glucopyranoside: Side chain conformations of the 2-amino-2-deoxy and 2,6-diamino-2,6-dideoxyglucopyranosides.

Authors:  Takayuki Kato; Andrea Vasella; David Crich
Journal:  Carbohydr Res       Date:  2017-05-19       Impact factor: 2.104

2.  Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatases.

Authors:  Tristan Reuillon; Sari F Alhasan; Gary S Beale; Annalisa Bertoli; Alfie Brennan; Celine Cano; Helen L Reeves; David R Newell; Bernard T Golding; Duncan C Miller; Roger J Griffin
Journal:  Chem Sci       Date:  2016-01-11       Impact factor: 9.825

3.  Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Authors:  Sari F Alhasan; Beate Haugk; Laura F Ogle; Gary S Beale; Anna Long; Alastair D Burt; Dina Tiniakos; Despina Televantou; Fareeda Coxon; David R Newell; Richard Charnley; Helen L Reeves
Journal:  Br J Cancer       Date:  2016-08-25       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.